Nature Communications (Nov 2019)
Engineering dendritic cell vaccines to improve cancer immunotherapy
Abstract
Dendritic cells (DCs) have been explored as a promising strategy for cancer immunotherapy. In this Perspective, the authors discuss the different types of DCs and their therapeutic potential in the context of vaccines for personalized cancer therapy.